Control of Metastases via Myeloid CD39 and NK Cell Effector Function
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Immunology Research"
DOI: 10.1158/2326-6066.cir-19-0749
Abstract: A CD39-targeting monoclonal antibody (B66) has potent activity in experimental and spontaneous metastases models. Myeloid cell, but not NK cell, expression of CD39 is critical for efficacy of the antibody and NK cell–mediated control of… read more here.
Keywords: anti cd39; cd39; control metastases; cell effector ... See more keywords